Diabetisk retinopati

Jakob Grauslund; Nis Andersen; Jens Andresen; Toke Bek; Sara Brandi; Javad Nouri Hajari; Søren Tang Knudsen; Caroline Schmidt Laugesen; Majbrit Lind; Mette Slot Nielsen; Katja Schielke; Yousif Subhi

doi:10.61409/V04240246

Diabetisk retinopati

Jakob Grauslund^*, Nis Andersen, Jens Andresen, Toke Bek, Sara Brandi, Javad Nouri Hajari, Søren Tang Knudsen, Caroline Schmidt Laugesen, Majbrit Lind, Mette Slot Nielsen, Katja Schielke, Yousif Subhi

^*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Abstract

Diabetic retinopathy (DR) is the most common complication in patients with diabetes, and screening for sight-threatening end-stages is indicated to avoid severe visual loss. Screening of DR is nationally implemented in Denmark according to evidence-based national guidelines, which includes the use of individualised screening intervals. Treatment is indicated for proliferative DR and diabetic macular oedema, and treatment modalities include retinal laser therapy, intravitreal angiostatic therapy, and vitrectomy. In this review, we summarise the current guidelines for screening and treatment of DR in Denmark.

Bidragets oversatte titel	Diabetic retinopathy
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Læger
ISSN	0041-5782
DOI	https://doi.org/10.61409/V04240246
Status	E-pub ahead of print - 9. sep. 2024

Dokumenter og links

10.61409/V04240246Licens: CC BY-NC-ND

Citationsformater

@article{7a332507f6d240a7a79665719f45ce1a,

title = "Diabetisk retinopati",

abstract = "Diabetic retinopathy (DR) is the most common complication in patients with diabetes, and screening for sight-threatening end-stages is indicated to avoid severe visual loss. Screening of DR is nationally implemented in Denmark according to evidence-based national guidelines, which includes the use of individualised screening intervals. Treatment is indicated for proliferative DR and diabetic macular oedema, and treatment modalities include retinal laser therapy, intravitreal angiostatic therapy, and vitrectomy. In this review, we summarise the current guidelines for screening and treatment of DR in Denmark.",

author = "Jakob Grauslund and Nis Andersen and Jens Andresen and Toke Bek and Sara Brandi and Hajari, {Javad Nouri} and Knudsen, {S{\o}ren Tang} and {Schmidt Laugesen}, Caroline and Majbrit Lind and {Slot Nielsen}, Mette and Katja Schielke and Yousif Subhi",

year = "2024",

month = sep,

day = "9",

doi = "10.61409/V04240246",

language = "Dansk",

journal = "Ugeskrift for L{\ae}ger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

}

TY - JOUR

T1 - Diabetisk retinopati

AU - Grauslund, Jakob

AU - Andersen, Nis

AU - Andresen, Jens

AU - Bek, Toke

AU - Brandi, Sara

AU - Hajari, Javad Nouri

AU - Knudsen, Søren Tang

AU - Schmidt Laugesen, Caroline

AU - Lind, Majbrit

AU - Slot Nielsen, Mette

AU - Schielke, Katja

AU - Subhi, Yousif

PY - 2024/9/9

Y1 - 2024/9/9

N2 - Diabetic retinopathy (DR) is the most common complication in patients with diabetes, and screening for sight-threatening end-stages is indicated to avoid severe visual loss. Screening of DR is nationally implemented in Denmark according to evidence-based national guidelines, which includes the use of individualised screening intervals. Treatment is indicated for proliferative DR and diabetic macular oedema, and treatment modalities include retinal laser therapy, intravitreal angiostatic therapy, and vitrectomy. In this review, we summarise the current guidelines for screening and treatment of DR in Denmark.

AB - Diabetic retinopathy (DR) is the most common complication in patients with diabetes, and screening for sight-threatening end-stages is indicated to avoid severe visual loss. Screening of DR is nationally implemented in Denmark according to evidence-based national guidelines, which includes the use of individualised screening intervals. Treatment is indicated for proliferative DR and diabetic macular oedema, and treatment modalities include retinal laser therapy, intravitreal angiostatic therapy, and vitrectomy. In this review, we summarise the current guidelines for screening and treatment of DR in Denmark.

U2 - 10.61409/V04240246

DO - 10.61409/V04240246

M3 - Tidsskriftartikel

SN - 0041-5782

JO - Ugeskrift for Læger

JF - Ugeskrift for Læger

ER -

Diabetisk retinopati

Abstract

Dokumenter og links

Fingeraftryk

Citationsformater